J&J filed a lawsuit Tuesday in the US District Court for the District of Columbia alleging the US Health Resources and ...

Building upon a successful end-of-Phase 2 meeting, received FDA "Study ... and business fronts,” said Stephen Brady, ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello everyone, and welcome to the Mirum Pharmaceuticals’ Third ...

In August, Trump said he wouldn't rule out taking away access to mifepristone, which was also mentioned by the policy ...

A new study found that many people on Medicare with low to moderate incomes don't have enough money to pay for a hospital ...

The Mediterranean diet is a healthy eating plan based on the cultures of Mediterranean countries. It includes beverages such ...

AstraZeneca said it is doubling down on its investment in its U.S. business. Meanwhile, General Catalyst has agreed to ...

President-elect Donald Trump made many promises on the campaign trail. He said he would eliminate taxes on tips and overtime pay, deport masses of undocumented immigrants and solve the conflict in the ...

Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...